increased hepatocellular carcinoma incidence_Ndrg2<tm1Kmori>/Ndrg2<+>

http://metadb.riken.jp/0003331IC57BL6C57BL6NCrljCBAJNCrljNdrg2tm1KmoriNdrg2Ndrg2tm1KmoriNdrg2

increased hepatocellular carcinoma incidence_Ndrg2<tm1Kmori>/Ndrg2<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• N-myc downstream regulated gene 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:1352498

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Ndrg2<tm1Kmori>/Ndrg2<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Ndrg2<tm1Kmori>|Ndrg2<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased hepatocellular carcinoma incidence
  http://purl.obolibrary.org/obo/MP_0003331

文献

http://purl.org/net/cito/citesAsAuthority

• Shingo. Nakahata, et.al., Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers., Nature communications, 2014, 5
  http://rdf.ncbi.nlm.nih.gov/pubmed/24569712